ATE386119T1 - Vier-helix bündelprotein zsig81 - Google Patents

Vier-helix bündelprotein zsig81

Info

Publication number
ATE386119T1
ATE386119T1 AT00942653T AT00942653T ATE386119T1 AT E386119 T1 ATE386119 T1 AT E386119T1 AT 00942653 T AT00942653 T AT 00942653T AT 00942653 T AT00942653 T AT 00942653T AT E386119 T1 ATE386119 T1 AT E386119T1
Authority
AT
Austria
Prior art keywords
zsig81
helix bundle
bundle protein
directed
well
Prior art date
Application number
AT00942653T
Other languages
English (en)
Inventor
Christopher Piddington
James West
Richard Holly
Steven Burkhead
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE386119T1 publication Critical patent/ATE386119T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00942653T 1999-06-01 2000-06-01 Vier-helix bündelprotein zsig81 ATE386119T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32358299A 1999-06-01 1999-06-01

Publications (1)

Publication Number Publication Date
ATE386119T1 true ATE386119T1 (de) 2008-03-15

Family

ID=23259830

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00942653T ATE386119T1 (de) 1999-06-01 2000-06-01 Vier-helix bündelprotein zsig81

Country Status (9)

Country Link
EP (1) EP1181369B1 (de)
JP (1) JP2003501034A (de)
AT (1) ATE386119T1 (de)
AU (1) AU5724700A (de)
CA (1) CA2414214A1 (de)
DE (1) DE60038020T2 (de)
IL (1) IL146847A0 (de)
MX (1) MXPA01012384A (de)
WO (1) WO2000073459A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130720D0 (en) * 2001-12-21 2002-02-06 Serono Internat S A Proteins

Also Published As

Publication number Publication date
DE60038020T2 (de) 2009-02-05
MXPA01012384A (es) 2002-09-02
CA2414214A1 (en) 2000-12-07
JP2003501034A (ja) 2003-01-14
EP1181369A1 (de) 2002-02-27
EP1181369B1 (de) 2008-02-13
DE60038020D1 (de) 2008-03-27
AU5724700A (en) 2000-12-18
WO2000073459A1 (en) 2000-12-07
IL146847A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
DK1317537T3 (da) Sammensætninger og fremgangsmåder med G-CSF analoger
UA84387C2 (ru) Человеческий цитокин как лиганд зальфа рецептора и его применение
DE69026627D1 (de) Antikörperantagonisten gegen humanes interleukin-4
NO965627D0 (no) Nytt cytokin betegnet lerk-5
EA200001023A1 (ru) Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью
ATE265219T1 (de) Verwendung von cxcr4 antagonisten zur behandlung von krebs und autoimmunkrankheiten
PT87138A (pt) Process for the preparation of adn recombinant molecules codin g polypeptide adn segments and of antibody compositions relate d with human tissue factor
NO990086L (no) Avkortete, l°selige tumornekrosefaktorreseptorer av type I og type II
ATE112687T1 (de) Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen.
ATE500323T1 (de) Subtilisin-variante
DK1513937T3 (da) Fremgangsmåde til den samtidige produktion af multiple proteiner; vektorer og celler til anvendelse derved
TR200001861T2 (tr) Yeni G protein birleştirilmiş alıcı
ES2052580T3 (es) Nuevas formas de factor-1 estimulante de colonias.
ATE387458T1 (de) Fas-antigenbindender ligand
DK1032672T3 (da) DNA19355-polypeptid, en tumornekrosefaktor-homolog
DK0901526T3 (da) Cortistatin: neuropeptider, sammensætninger og metoder
ATE386119T1 (de) Vier-helix bündelprotein zsig81
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
EP0676413A3 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung.
PT977859E (pt) O factor neurotrofico nnt-1
WO2000053785A3 (en) Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins
DE60231816D1 (de) Menschliche alpha2-delta4-calciumkanal-untereinheit codierende cdna
EA199900663A1 (ru) Новые белки, связывающиеся с рецептором 1 интерферона, кодирующая их днк и способы модуляции клеточного ответа на интерфероны
UA84540C2 (en) Novel cytokine zcytor17 ligand
DE60209797D1 (de) Antikörper zur stimulierung der produktion von il-1ra

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1181369

Country of ref document: EP

REN Ceased due to non-payment of the annual fee